[HTML][HTML] Parkinson disease-associated cognitive impairment
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
Cognition deficits in Parkinson's disease: mechanisms and treatment
C Fang, L Lv, S Mao, H Dong, B Liu - Parkinson's disease, 2020 - Wiley Online Library
Parkinson's disease (PD) is the second most common progressive neurodegenerative
disorder mainly in middle‐elderly population, which represents diverse nonmotor symptoms …
disorder mainly in middle‐elderly population, which represents diverse nonmotor symptoms …
Extracellular vesicle biomarkers for cognitive impairment in Parkinson's disease
Besides motor symptoms, many individuals with Parkinson's disease develop cognitive
impairment perhaps due to coexisting α-synuclein and Alzheimer's disease pathologies and …
impairment perhaps due to coexisting α-synuclein and Alzheimer's disease pathologies and …
Research evidence of the role of the glymphatic system and its potential pharmacological modulation in neurodegenerative diseases
JP Verghese, A Terry, ER de Natale… - Journal of Clinical …, 2022 - mdpi.com
The glymphatic system is a unique pathway that utilises end-feet Aquaporin 4 (AQP4)
channels within perivascular astrocytes, which is believed to cause cerebrospinal fluid …
channels within perivascular astrocytes, which is believed to cause cerebrospinal fluid …
The role of amyloids in Alzheimer's and Parkinson's diseases
With varying clinical symptoms, most neurodegenerative diseases are associated with
abnormal loss of neurons. They share the same common pathogenic mechanisms involving …
abnormal loss of neurons. They share the same common pathogenic mechanisms involving …
Pathological influences on clinical heterogeneity in Lewy body diseases
DG Coughlin, HI Hurtig, DJ Irwin - Movement Disorders, 2020 - Wiley Online Library
ABSTRACT PD, PD with dementia, and dementia with Lewy bodies are clinical syndromes
characterized by the neuropathological accumulation of alpha‐synuclein in the CNS that …
characterized by the neuropathological accumulation of alpha‐synuclein in the CNS that …
[HTML][HTML] Amyloid-beta and tau protein beyond Alzheimer's disease
The aggregation of amyloid-beta peptide and tau protein dysregulation are implicated to
play key roles in Alzheimer's disease pathogenesis and are considered the main …
play key roles in Alzheimer's disease pathogenesis and are considered the main …
[HTML][HTML] The consequences of sleep deprivation on cognitive performance
MA Khan, H Al-Jahdali - Neurosciences Journal, 2023 - nsj.org.sa
Although not fully understood, sleep is accepted as a vital and organized sequence of
events that follows a regular cyclic program each night to ensure the human body can …
events that follows a regular cyclic program each night to ensure the human body can …
Morphological basis of Parkinson disease-associated cognitive impairment: an update
KA Jellinger - Journal of Neural Transmission, 2022 - Springer
Cognitive impairment is one of the most salient non-motor symptoms of Parkinson disease
(PD) that poses a significant burden on the patients and carers as well as being a risk factor …
(PD) that poses a significant burden on the patients and carers as well as being a risk factor …
Pathobiology of cognitive impairment in Parkinson disease: challenges and outlooks
KA Jellinger - International Journal of Molecular Sciences, 2023 - mdpi.com
Cognitive impairment (CI) is a characteristic non-motor feature of Parkinson disease (PD)
that poses a severe burden on the patients and caregivers, yet relatively little is known about …
that poses a severe burden on the patients and caregivers, yet relatively little is known about …